Brianna N. Smith
Affiliations: | 2018- | Cancer Biology | Vanderbilt University, Nashville, TN |
Google:
"Brianna Smith"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Meyer CT, Smith BN, Wang J, et al. (2024) Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies. Proceedings of the National Academy of Sciences of the United States of America. 121: e2408889121 |
Howard GC, Wang J, Rose KL, et al. (2024) Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. Elife. 12 |
Monteith AJ, Ramsey HE, Silver AJ, et al. (2024) Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia. Cancer Research |
Ramsey HE, Gorska AE, Smith BN, et al. (2023) TLR3 agonism augments CD47 inhibition in acute myeloid leukemia. Haematologica |
Howard GC, Wang J, Rose KL, et al. (2023) Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. Biorxiv : the Preprint Server For Biology |
Fischer MA, Song Y, Arrate MP, et al. (2022) Selective inhibition of MCL1 overcomes venetoclax-resistance in a murine model of myelodysplastic syndromes. Haematologica |
Cojocari D, Smith BN, Purkal JJ, et al. (2021) Pevonedistat and azacitidine upregulate NOXA () to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia. Haematologica |
Villaume MT, Arrate MP, Ramsey HE, et al. (2021) The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib. Experimental Hematology |
Smith BN, Savona M, Komrokji RS. (2019) Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN). Clinical Lymphoma, Myeloma & Leukemia. 19: 1-8 |
Hilton CB, Meggendorfer M, Sekeres MA, et al. (2019) Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms Blood. 134: 4238-4238 |